Traumatic injury to the brain, spinal cord and optic nerve in the central nervous system (CNS) are the leading cause of disability and the second leading cause of death worldwide. CNS injuries often result in a catastrophic ...
Jan 19, 2023
0
1470
A universal criteria for diagnosing the blinding eye condition optic neuritis has been developed by a UCL-led team of researchers.
Jan 12, 2023
0
4
A comprehensive eye exam could be the key to determining if you have glaucoma, a silent thief of sight.
Jan 4, 2023
0
15
Glaucoma is the leading cause of irreversible blindness due to optic nerve damage and the death of retinal ganglion cells (RGCs). Presently, reducing intraocular pressure is the sole evidence-based therapy for glaucoma patients, ...
Dec 20, 2022
0
45
A new study from UCLA researchers identified an animal model that could be used to study treatments for improving disabilities in multiple sclerosis patients.
Oct 25, 2022
0
38
More than half of sightless children in the United States did not have to lose their vision, according to a new study.
Oct 5, 2022
0
7
A large, nationwide study from Taiwan shows that people with a specific type of glaucoma, called normal-tension glaucoma, are at high risk for developing Alzheimer's disease. The researchers say people with this type of glaucoma ...
Sep 30, 2022
0
28
The earlier individuals develop type 2 diabetes or hypertension in life, the earlier they are likely to develop primary open-angle glaucoma (POAG), the leading cause of irreversible blindness worldwide, researchers from ...
Aug 29, 2022
0
34
A new, non-invasive ocular imaging method may be able to detect an early indicator of glaucoma in time to prevent disease progression and vision loss, according to a new study from New York Eye and Ear Infirmary of Mount ...
Aug 2, 2022
0
6
Research from a team including the Crabb Lab at City, University of London has used "deep learning" (DL), which is a type of artificial intelligence (AI), on thousands of images of the backs of the eyes of glaucoma patients ...
Jun 7, 2022
0
90
